Basecamp Research Product Lead, Peptide Therapeutics at Basecamp Research owns the peptide platform as a commercial product. Responsible for market analysis, target product profiles, and positioning for peptide therapeutics.
Responsibilities
We are seeking a highly capable and proactive Product Lead, Peptide Therapeutics to join our Boston, USA team, initially reporting into our Chief Technology Officer. This role owns the peptide platform as a commercial product: the market analysis behind it, the target product profiles it is judged against, the decisions about what we build and license first, and the positioning that partners hear. You will sit between our model and science teams and our business development function, and you will be accountable for the peptide portfolio having a defined buyer, a defensible claim and a credible price.
Market and competitive intelligence
Build and maintain a rigorous view of the peptide therapeutics landscape by segment, indication and modality, including approved agents, late-stage pipelines, mechanism trends and delivery technologies.
Track and interpret competitor activity across AI-enabled discovery platforms, peptide-focused biotechs, display and screening technology providers, and internal pharmaceutical capability, and translate it into implications for our roadmap and pricing.
Maintain a live map of deal structures, comparables and valuation benchmarks in platform licensing and co-development, and advise on where our agreements should sit.
Bring the outside in: run structured voice-of-customer work with pharmaceutical R&D leaders, and turn it into prioritised, written requirements rather than anecdotes.
Target product profiles and programme definition
Author and defend target product profiles for internal peptide programmes, specifying which properties are load-bearing, which are desirable, and what evidence would falsify the case.
Translate partner-supplied target product profiles into feasible research plans in collaboration with scientific leadership, including honest assessments of what our platform can and cannot address today.
Define stage gates and go or no-go criteria for peptide programmes, and make the recommendation when a programme should stop.
Productisation and roadmap
Decide, on evidence, which platform capabilities become licensable products and in what sequence, balancing near-term revenue against durable differentiation.
Qualification
Credibility in both directionsExcellent written EnglishWillingness to travel internationallyAdvantageous Skills and ExperienceExperience in metabolic diseaseFamiliarity with macrocyclic peptides
Required
10+years in the pharmaceutical or biotechnology industry, with substantial exposure to peptide, protein or biologics therapeutics in discovery, development, product strategy or business development.
Demonstrable command of what makes peptides difficult as drugs: proteolytic stability, oral and systemic exposure, receptor selectivity and off-target risk, immunogenicity, formulation and manufacturability, and the trade-offs between them.
A track record of shaping and closing partnerships, licensing agreements or platform deals with pharmaceutical companies, or of owning commercial strategy for a platform sold into pharmaceutical R&D.
Proven ability to author target product profiles, competitive assessments and commercial cases that senior stakeholders act on.
Credibility in both directions: able to hold a substantive technical discussion with computational and experimental scientists, and a commercial discussion with a vice-president of platform technologies, without over-claiming in either.
Comfort operating with incomplete evidence, and the discipline to distinguish clearly between what is validated, what is promising and what is aspiration.
Excellent written English. A great deal of this role is producing documents that must be right.
Willingness to travel internationally, typically once or twice a month.
Advantageous Skills and Experience
Experience in metabolic disease, immunology, anti-infectives or another therapeutic area with an active peptide pipeline.
Familiarity with macrocyclic peptides, peptidomimetics, non-canonical amino acids, conjugation strategies or oral delivery technologies.
Direct experience of AI-enabled drug discovery platforms, from either the platform side or the pharmaceutical side of a partnership.